SAP Just Overtook Ozempic Maker Novo Nordisk as Europe's Most Valuable - Barron's
1. NVO's stock dropped 1.3%, losing its crown as Europe's largest company. 2. Its market cap is now around $337.79 billion. 3. NVO has declined 41% this past year amid waning weight-loss drug demand. 4. SAP's shares rose 1.3%, boosting its market cap to $339.47 billion. 5. Sector shifts show a rotation from U.S. to European stocks.